EVMN
#2942
Evommune, Inc. Common Stock
13.2 7 USD
-0.01%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-1.19%
Variación mensual
+19.44%
Variación en los últimos 6 meses
-47.00%
Cambio anual
-23.38%
Cierres anteriores
13.4 3
Open
13.3 7
Mínimo
13.2 4
Máximo
13.3 7
Volumen
25
Financials
- Market Capitalization 481.6 M
- Employee 48
- Founded 2020
- CEO N/A
- Website www.evommune.com
- Headquarter Delaware, United States
- FIGI BBG00Y79N887
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-1.53
Relación precio/flujo de caja
8.08
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2894 |  KYTX Kyverna Therapeutics, Inc. - Common Stock | 8.47 USD | -1.97% | +2.42% | +12.93% | +117.18% | 523.81 M USD | ||
| 2911 |  EDIT Editas Medicine, Inc. - Common Stock | 3.32 USD | +0.61% | +7.79% | +27.69% | +25.28% | 509.89 M USD | ||
| 2947 |  CCCC C4 Therapeutics, Inc. - Common Stock | 3.89 USD | -5.12% | -3.23% | +12.75% | +53.75% | 478.57 M USD | ||
| 2950 |  PRTA Prothena Corporation plc - Ordinary Shares | 9.31 USD | +2.42% | -0.43% | +7.75% | +12.58% | 477.95 M USD |